Genixus, a United States-based pharmaceutical company, has named Seth Coombs as its new chief commercial officer and Don Anthony JD PhD as its new executive vice president, global head of Intellectual Property, it was reported on Tuesday.
Prior to joining Genixus, Coombs has served Novartis in roles of increasing responsibility across three divisions. He has held the position of vice president, Commercial Operations & Alliance Management at Novartis' Sandoz division. He has also served as vice president, Oncology and Injectable products for Sandoz US and held several senior roles within Novartis Vaccines and Diagnostics.
Dr Anthony is an attorney focused on intellectual property and commercial pharmaceutical law. He has held various roles of increasing responsibility at various pharmaceutical companies, which includes senior vice president of Intellectual Property at Mayne Pharma.
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine
Virbac expands presence in Japan with Sasaeah acquisition
Pfizer reveals strong efficacy data for ABRYSVO in older adults against RSV